EFNA5 and nonpapillary renal cell carcinoma: Moreover, an association between the mRNA level of EFNA5 and DNA methylation of its promoter were documented for ccRCC, chRCC, pRCC, mesothelioma, prostate cancer, thymoma, and diffuse large B-cell lymphoma.